Covid-19 At Home Tests

Beginning January 15, 2022, FDA approved over the counter COVID-19 diagnostic tests are reimbursable at no cost per federal guidance and mandate. FDA approved tests will either be covered as a prescription billed to the prescription drug coverage plan, AmWINS Rx, at the point of sale with an in-network pharmacy or will be reimbursable, if a member paid out-of-pocket on or after January 15, 2022.